China-Biotics, Inc. (CHBT) Downgraded to Sell at Maxim Group

China-Biotics, Inc. (CHBT) has been downgraded today by the securities  research analysts at investment firm Maxim Group which downgraded CHBT from a “hold” rating to “sell.”  Maxim has a performance outlook price target of $6 dollars on CHBT.  CHBT is down during intraday trading and has trended beneath intermediate support of the $7.22 price level.

China-Biotics is slated to release their next earnings report next Thursday on June 9th, 2011 and the current EPS consensus estimate is 51 cents.  Their last earnings report was released on February 11th, 2011 and announced EPS of 47 cents with revenue totaling $32.4 million which was up 39.1 % year to year.  CHBT is currently trading below its 50 & 200-day moving averages and 2011 is a down year for the company.

China-Biotics, Inc. is engaged in the research, development, production, marketing, and distribution of probiotics products, which are products that contain live microbial food supplements that beneficially affect the host by improving its intestinal microbial balance. The company has market capitalization of $141,000,000 and 22,150,000 shares outstanding.  CHBT has a 52-week high of $17.90 with the low being $6.78 dollars.



Latest News

Traders Sell iShares iBoxx $ High Yield Corporate Bond ETF  on Strength
Traders Sell iShares iBoxx $ High Yield Corporate Bond ETF on Strength
Investors Sell Shares of Elanco Animal Health  on Strength
Investors Sell Shares of Elanco Animal Health on Strength
Iconiq Lab Token Tops One Day Volume of $82.00
Iconiq Lab Token Tops One Day Volume of $82.00
eXPerience Chain  Trading 0.2% Lower  Over Last Week
eXPerience Chain Trading 0.2% Lower Over Last Week
1X2 COIN Market Cap Hits $0.00
1X2 COIN Market Cap Hits $0.00
Investors Buy SPDR S&P Bank ETF  on Weakness
Investors Buy SPDR S&P Bank ETF on Weakness


© 2006-2019 Ticker Report